In patients with obesity and diabetes, altered acetylation or phosphorylation of mTOR disrupts its role in insulin signaling, impairing glucose metabolism and contributing to insulin resistance. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.